The treatment of foveal central serous choroidopathy by krypton red laser.
We present 24 patients with recent foveal central serous choroidopathy. Only those in whom the leakage site was located within a radius of 250 microns from the foveal center were included in this study. All patients were treated with the krypton red laser (647 nm) within a week of the clinical diagnosis. At the end of the follow-up, 70.8% of the patients had a visual acuity of 6/8.5 or better, and an overall visual improvement was found in 83.3%. In 90% of the patients whose vision improved, significant absorption of subretinal fluid was seen within three weeks and in 10% within four weeks. No evidence of any macular pathology complicating the laser treatment was found at the end of the follow-up period of at least 36 months.
Weinberger
D
D
Dept. of Ophthalmology, Beilinson Medical Center, Petah Tiqva, Israel.
Kremer
I
I
Ben Sira
I
I
D000328:Adult; D015862:Choroid Diseases / Q000601:surgery*; D005260:Female; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D005584:Fovea Centralis / Q000601:surgery*; D005654:Fundus Oculi; D006801:Humans; D007726:Krypton; D053685:Laser Therapy / Q000009:adverse effects; D008266:Macula Lutea / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D012163:Retinal Detachment / Q000601:surgery*; D014792:Visual Acuity
D007726:Krypton